Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PANGEA: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma

NCT02213289 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT02213289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PANGEA: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
January 20, 2015
Completion date
August 20, 2020
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma